z-logo
open-access-imgOpen Access
Elevated advanced oxidation protein products levels in patients with liver cirrhosis.
Author(s) -
Jolanta Zuwała−Jagiełło,
Monika PazganSimon,
Krzysztof Simon,
Maria Warwas
Publication year - 2009
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2009_2502
Subject(s) - cirrhosis , medicine , oxidative stress , gastroenterology , liver disease , glycation , receptor
Serum concentrations of advanced oxidation protein products (AOPPs) and glycation end products (AGEs) were assessed with respect to functional compromise of liver, as determined by the Child-Pugh and MELD scores. Patients with decompensated liver cirrhosis (Child-Pugh B and C) exhibited significantly higher serum concentrations of AOPPs than both patients with compensated liver cirrhosis (Child-Pugh A) and controls. The levels of plasma AGEs in all liver cirrhotic patients were higher when compared with those with the controls and this difference was statistically significant. Plasma total antioxidant status of the patients was significantly lower than that of controls. Significant positive correlations between AOPPs level and the MELD score and between the oxidative stress index and the MELD score were found in all patients with liver cirrhosis. Altered AOPPs levels in decompensated patients may influence the potency of oxidative stress and the progression of liver disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom